Exome and genome sequencing studies of large ASD cohorts have confirmed PTEN as well-established risk gene for ASD and neurodevelopmental disorders [14–20], and recent case series have suggested that 25–50% of children with PTEN mutations are identified with ASD [21, 22]. The gene discussed is PTEN; the disease is neurodevelopmental disorder.